Pharmaceutical News

RSS

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved its New Drug Application for Nymalize (nimodipine) oral solution.

14 May 2013

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

A large-scale National Eye Institute study has shown fish oil supplements containing omega-3 fatty acids do not alter the progression of age-related macular degeneration, says a national team of researchers including David M. Brown, M.D., an retina specialist at The Methodist Hospital who ran Houston's part of the study.

14 May 2013

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a combination of drugs to potentially treat chronic lymphocytic leukemia more effectively.

14 May 2013

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

Some parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.

14 May 2013

FDA grants priority review for Janssen's simeprevir

Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

14 May 2013

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Biogen Idec announced today that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for the marketing approval of ELOCTATE (recombinant factor VIII Fc fusion protein) for the treatment of hemophilia A.

13 May 2013

BioGaia inks distribution agreement for ProTectis baby drops and tablets in China

BioGaia has signed an agreement with Beijing Keyuan Xinhai Pharmaceutical Co Ltd for the exclusive rights to sell BioGaia's ProTectis baby drops and ProTectis and Gastrus tablets through the retail pharmacy channel in China from 2013.

13 May 2013

CompCare, UticaCSD sign Pharmacy Savings Management Agreement

Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management services provider for employers, Taft-Hartley health and welfare Funds, and managed care companies throughout the U.S., today announced the signing of a Pharmacy Savings Management Agreement with Utica City School District.

13 May 2013

Study confirms that success of sunless tanning products depends on young women

Sunless tanning - whether with lotions, bronzers or tanning pills - has been promoted as an effective substitute to dodge the health risks of ultraviolet rays, but if the products don't provide the perfect tan, young women likely will not use them, according to a Baylor University researcher.

13 May 2013

Senate bill on FDA oversight of compounding pharmacies gets broad backing as hearings move closer

A bill to give the FDA greater authority over compounding pharmacies like the one behind a deadly meningitis outbreak gets broad -- including bipartisan -- backing, and a key committee chairman readies a hearing on the legislation.

13 May 2013

Scientists make novel discoveries concerning current vaccine against whooping cough

Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine.

13 May 2013

Researchers successfully test new anti-cocaine vaccine in primates

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials.

13 May 2013

Researchers identify clue to explain the reversible memory loss caused by statins

The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs.

13 May 2013

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

13 May 2013

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers at the Knight Cancer Institute at Oregon Health & Science University.

13 May 2013

Study: Metformin may not improve survival rates after breast cancer

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

10 May 2013

Cinnamon-flavored foods contain high levels of natural substance that may cause liver damage

Many kinds of cinnamon, cinnamon-flavored foods, beverages and food supplements in the United States use a form of the spice that contains high levels of a natural substance that may cause liver damage in some sensitive people, scientists are reporting. Their study, published in ACS' Journal of Agricultural and Food Chemistry, found similar results as those published in the European Union.

10 May 2013

Pharmaceutical News

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

FDA grants priority review for Janssen's simeprevir

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

BioGaia inks distribution agreement for ProTectis baby drops and tablets in China

CompCare, UticaCSD sign Pharmacy Savings Management Agreement

Study confirms that success of sunless tanning products depends on young women

Senate bill on FDA oversight of compounding pharmacies gets broad backing as hearings move closer

Scientists make novel discoveries concerning current vaccine against whooping cough

Researchers successfully test new anti-cocaine vaccine in primates

Researchers identify clue to explain the reversible memory loss caused by statins

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Study: Metformin may not improve survival rates after breast cancer

Cinnamon-flavored foods contain high levels of natural substance that may cause liver damage

DURECT: Pfizer provides update on investigational drug Remoxy

Expiring patents drive drug spending's first time fall

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News